BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD4956 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD4956\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07446855-11174@assetmemo.bio
DTSTAMP:20261121T004552Z
DTSTART;VALUE=DATE:20300329
DTEND;VALUE=DATE:20300330
SUMMARY:AZD4956: Phase 1/2 readout est. (NCT07446855)
DESCRIPTION:AZD4956\, phase 1/2.\nStudy: Study of AZD4956 as Monotherapy an
 d in Combination With Anti-Cancer Agents in Participants With Advanced/Met
 astatic Homologous Recombination Deficient Solid Tumours\nEstimated primar
 y completion: 29 March 2030. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/azd4956#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07446855
URL:https://assetmemo.bio/drug/azd4956#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
